API Active Pharmaceutical Ingredients

API Active Pharmaceutical Ingredients
Abumec Pharmaceuticals Ltd’s API (Active Pharmaceutical Ingredients) division has been a cornerstone of our operations since its inception in 1996. With a clear focus on facilitating the manufacture of niche molecules, we have leveraged vertical integration to bring the benefits of our products to international and domestic markets alike.

Our API business boasts a wealth of competence and knowledge, enabling us to undertake over 30 different types of complex chemical reactions. Whether it’s Advanced Intermediates, Fine Chemicals, or Active Pharmaceutical Ingredients, we possess the capability to seamlessly scale up production from MG to MT quantities. Our facilities include state-of-the-art Pilot and Commercial Scale multipurpose units, pharmaceutical manufacturing plants adhering to GMP guidelines, and R&D facilities supporting the early development of Generic APIs.

At Abumec Pharmaceuticals Ltd, we prioritize innovation and quality, offering patent non-infringing processes and maintaining high-quality documents such as Drug Master Files. Our API products have gained recognition and acceptance in numerous countries, including Japan, Australia, Spain, the UK, Canada, Nigeria, and many more.

Our extensive range of APIs encompasses various therapeutic categories, including Anti-Histamine, Platelet Inhibitors, Anti-Diabetics, Anti-Convulsants, Urinary Incontinence medications, Neuropathic Pain relievers, Anti-Allergy drugs, Anti-Inflammatory agents, Diuretics, and Acne Treatments.

Furthermore, our manufacturing plant holds various accreditations, underscoring our commitment to upholding the highest standards of quality, safety, and regulatory compliance in all our operations.